Clinical Trial Update: Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety of VT-5006 in healthy volunteers and individuals with Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VT-5006 (VT-5006)

Snippet

Sponsor: Vertero Therapeutics | Conditions: Healthy Volunteers (HV), Parkinson's Disease (PD) | Phase 1 | Status: RECRUITING